Aquestive Therapeutics Inc.
AQST | NASDAQ
$4.78
+$0.17 (+3.69%)
At close: Sep 21, 2026, 4:00 PM ET
$4.74
-$0.04 (-0.84%)
After-hours:
Sep 21, 2026, 7:59 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -8.50 | -6.98 | -15.54 | -0.81 | -2.10 | -3.22 |
PEG Ratio | -0.17 | -0.02 | 0.18 | 0.02 | -0.18 | 0.08 |
PS Ratio | 17.69 | 5.36 | 2.45 | 0.92 | 2.91 | 3.93 |
PB Ratio | -23.41 | -5.13 | -1.16 | -0.37 | -1.80 | -3.71 |
P/FCF Ratio | -14.87 | -8.60 | -16.78 | -3.57 | -4.37 | -3.92 |
P/OCF Ratio | -15.03 | -8.63 | -19.39 | -4.49 | -4.49 | -3.96 |
OCF/S Ratio | -117.71 | -62.12 | -12.61 | -20.53 | -64.88 | -99.15 |
Debt / Equity Ratio | -3.90 | -0.63 | -0.31 | -0.48 | -0.69 | -0.83 |
Quick Ratio | 3.01 | 4.36 | 1.87 | 0.86 | 1.97 | 2 |
Current Ratio | 3.14 | 4.68 | 2.24 | 1.01 | 2.15 | 2.11 |
Asset Turnover | 0.28 | 0.57 | 0.88 | 0.84 | 0.82 | 0.73 |
Interest Coverage | -4.07 | -1.83 | -2.02 | -3.38 | -1.54 | -3.29 |
Return on Equity | 248.90% | 73.37% | 7.39% | 45.89% | 85.88% | 115.02% |
Return on Assets | -52.23% | -43.52% | -13.71% | -95.34% | -113.79% | -88.71% |
Return on Invested Capital | -55.97% | -37.02% | -38.21% | -115.26% | -80.74% | -95.14% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 61.49% | 68.95% | 58.82% | 59.34% | 70.51% | 71.72% |
Net Profit Margin | -188.09% | -76.68% | -15.56% | -114.11% | -138.77% | -121.67% |
Pretax Profit Margin | -188.09% | -76.70% | -15.07% | -114.11% | -138.77% | -121.67% |
Operating Profit Margin | -156.36% | -53.46% | -29.86% | -88.23% | -68.22% | -93.55% |
FCF Margin | -118.97% | -62.40% | -14.58% | -25.82% | -66.67% | -100.28% |
EBITDA Margin | -148.45% | -46.24% | 2.34% | -83.01% | -88.75% | -85.40% |
Add to Watchlist
Select watchlists to add or remove AQST